DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies

Datavault AI is party to an amended and restated non-binding LOI under which DataMEDS AI (NASDAQ: MEDS) would expand its exclusive license of Datavault AI's healthcare-related intellectual property, with DVLT receiving equity participation in DataMEDS plus royalties on use of its technologies. The proposed transaction would also reunite the QOLPOM IP portfolio — biometric verification for drone and home drug delivery — from EOS Technology Holdings and Scilex, and have DataMEDS acquire a controlling interest in Tollo Health, targeting a Q4 2026 close.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.